TNFSF10 and cancer: Although TRAIL-expressing MSCs represent a promising approach, certain challenges remain—notably, cancer cell resistance to TRAIL-induced apoptosis [120], often due to low death receptor expression or upregulation of anti-apoptotic proteins [121].